medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2001, Number 4

<< Back Next >>

Rev Biomed 2001; 12 (4)

Interleukins and innate immunity.

Hernández-Urzúa MA, Alvarado-Navarro A

Language: Spanish
References: 61
Page: 272-280
PDF size: 89.84 Kb.


ABSTRACT

The communication between immune and inflammatory cells is mediated in large part by proteins, termed interleukins, which are able to promote cell growth, differentiation, and functional activation. These effector molecules are produced transiently and controll locally the amplitude and duration of the response. In this review, cytokinecell interactions as major biological characteristics of interleukins involved in innate immune response IL-1, IL-6, chemokines, IL-10, IL-12, IL-15, IL- 18, TNF-a and IFN-a, -b are outlined.


REFERENCES

  1. Fleisher TA, Bleesing JJ. Immune function. Pediatr Clin North Am 2000; 47:1197-209.

  2. Medzhitov R, Janeway CA Jr. Advances in Immunology: Innate Immunity. N Eng J Med 2000; 343: 338-44.

  3. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173:89-97.

  4. Seder RA, Gazzinelli RT. Cytokines are critical in linking the innate and adaptive immune responses to bacterial, fungal, and parasitic infection. Adv Intern Med 1999; 44:353-88

  5. Rollinghoff M. Immunity, components of the immune system and immune response. Biologicals 1997; 25:165-8.

  6. Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 1997; 9:17-23.

  7. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling--regulation of the immune response in normal and critically ill states. Crit Care Med 2000; 28 (Suppl):N3-12.

  8. Gery I, Waksman BH. Potentiation of the Tlymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med 1972; 136:143-55.

  9. Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16:457-99.

  10. Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, et al. Two interferon mRNAs in human fibroblats: In vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 1980; 77:7152-6.

  11. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819.

  12. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84: 9233-7.

  13. Ward SG, Westwick J. Chemokines: understanding their role in T-lymphocyte biology. Biochem J 1998; 333 (Pt 3):457-70.

  14. Moser B, Loetscher M, Piali L, Loetscher P. Lymphocyte responses to chemokines. Int Rev Immunol 1998; 16:323-44.

  15. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827- 45.

  16. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, et al. The interleukin-12/interleukin- 12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.

  17. Trinchieri G. Immunobiology of interleukin-12. Immunol Res 1998; 17:269-78.

  18. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc Natl Acad Sci USA 1957; 147:258.

  19. Sinigaglia F, D'Ambrosio D, Rogge L Type I interferons and the Th1/Th2 paradigm. Dev Comp Immunol 1999; 23:657-63.

  20. Carswell EA, Old LJ, Kaseel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necroses of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-74.

  21. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 1993; 187:317-29.

  22. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, et al. A lymphokine, provisionally designed interleukin T and produced by a human adult Tcell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994; 91:4935-9.

  23. Waldmann T, Tagaya Y, Bamford R. Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol 1998; 16:205-26.

  24. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-95.

  25. Stordeur P, Goldman M. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. Int Rev Immunol 1998; 16:501-22.

  26. Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989; 57:590-9.

  27. Lebel-Binay S, Berger A, Zinzindohoue F, Cugnenc P, Thiounn N, Fridman WH, et al. Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 2000 Mar;11:15-26.

  28. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103:11-24.

  29. Risso A. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J Leukoc Biol 2000; 68:785-92.

  30. Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000; 21:624-30.

  31. Nonaka M. Evolution of the complement system. Curr Opin Immunol 2001; 13:69-73.

  32. Zhang Y, Suankratay C, Zhang XH, Lint TF, Gewurz H. Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxininitiated hemolysis. Immunopharmacology 1999; 42:81-90.

  33. Ulevitch RJ, Tobias PS. Receptor-dependent mechanism of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13:437-57.

  34. Linehan SA, Martinez-Pomares L, Gordon S. Macrophage lectins in host defence. Microbes Infect 2000; 2:279-88.

  35. Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11:13-8.

  36. Stein-Streilein J, Sonoda KH, Faunce D, Zhang- Hoover J. Regulation of adaptive immune responses by innate cells expressing NK markers and antigentransporting macrophages. J Leukoc Biol 2000; 67:488-94.

  37. Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol 2000; 114:602-8.

  38. Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol 1999;26 (Suppl 57):16-21.

  39. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 1999; 20:254-7.

  40. Lukacs NW, Kunkel SL. Chemokines and their role in disease. Int J Clin Lab Res 1998; 28:91-5.

  41. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000; 12:64-76.

  42. Boyaka PN, Lillard JW Jr, McGhee J. Interleukin 12 and innate molecules for enhanced mucosal immunity. Immunol Res 1999; 20:207-17.

  43. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000; 12:59-63.

  44. Trinchieri G. Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 1998; 16: 365-96.

  45. Spellberg B, Edwards JE. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32:76-102.

  46. Yoshikai Y, Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect 2000; 2:381-9.

  47. Carson W, Caligiuri MA. Interleukin-15 as a potential regulator of the innate immune response. Braz J Med Biol Res 1998; 31:1-9.

  48. Vales-Gomez M, Reyburn H, Strominger J. Interaction between the human NK receptors and their ligands. Crit Rev Immunol 2000; 20:223-44.

  49. Meeusen EN, Balic A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000; 16: 95-101.

  50. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol 2000; 12:419-24.

  51. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999; 19:203-14.

  52. Gadient RA, Otten UH. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997; 52:379-90.

  53. DiPiro JT. Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacotherapy 1997; 17:205-23.

  54. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000;30 (Suppl 1):28-32.

  55. Smith EM, Cadet P, Stefano GB, Opp MR, Hughes TK Jr. IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 1999; 100:140-8.

  56. Opal SM, De Palo VA. Anti-inflammatory cytokines. Chest 2000; 117:1162-72.

  57. Ma X, Montaner LJ. Proinflammatory response and IL-12 expression in HIV-1 infection. J Leukoc Biol 2000; 68:383-90.

  58. McNicholl JM, Downer MV, Udhayakumar V, Alper CA, Swerdlow DL. Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera. Annu Rev Public Health 2000; 21:15-46.

  59. Gough PJ; Gordon S. The role of scavenger receptors in the innate immune system. Microbes Infect 2000; 2: 305-11.

  60. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9:4-9.

  61. Banyer JL, Hamilton NH, Ramshaw IA, Ramsay AJ. Cytokines in innate and adaptive immunity. Rev Immunogenet 2000; 2:359-73.




2020     |     www.medigraphic.com